Psychedelic Drugs Market Projected to Reach $6,859.95 Million by 2027

The psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD 6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugsContinue reading “Psychedelic Drugs Market Projected to Reach $6,859.95 Million by 2027”

Psychedelic Drugs Could Potentially Treat Impending Post-lockdown Mental Health Epidemic

Trials are already underway testing the use of psychedelics such as psilocybin, LSD, ketamine, ecstasy and other currently scheduled drugs to treat a mental health epidemic predicted to hit after the lockdown is over. New research in the USA is also pointing to antidepressants such as Prozac made by Eli Lilly and Company (NYSE:LLY) as a potential redirected treatment against the cause ofContinue reading “Psychedelic Drugs Could Potentially Treat Impending Post-lockdown Mental Health Epidemic”

Champignon Rises Another 28%, Sponsors Non-profit Coalition

Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences Company with an emphasis on ketamine and psychedelic medicine, is pleased to sponsor TheraPsil, a BC-based non-profit coalition of healthcare professionals, policy-makers and community leaders (the “TheraPsil Coalition”) seeking legal access to psilocybin for British Columbians with a palliative diagnosis and psychological distress.Continue reading “Champignon Rises Another 28%, Sponsors Non-profit Coalition”

Champignon Appoints Pat McCutcheon to Board of Directors

VANCOUVER, British Columbia, May 06, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the appointmentContinue reading “Champignon Appoints Pat McCutcheon to Board of Directors”